Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,240 Jan 1 – Oct 28, 2026
- Disclosed funding
- $257.2B 1859 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B Provides AI-powered voice coaching for non-native English speakers | $21M | Series A | Edtech | United States | Investors | |
| O OuttakeCompany profile Provides a unified platform for digital trust to detect, investigate, and disrupt identity-based ... Provides a unified platform for digital trust to detect, investigate, and disrupt identity-based ... | $40M | Series B | Cybersecurity | United States | Investors | |
 CellaresCompany profile Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network. Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network. | $257M | Series DSeries C+ | Biotech | United States | Investors | |
| C CheckboxCompany profile Provides AI-powered legal intake and workflow automation for in-house legal teams Provides AI-powered legal intake and workflow automation for in-house legal teams | $23M | Series A | Enterprise software | United States | Investors | |
 Adaptive6Company profile Adaptive6 helps enterprise engineering and FinOps teams find, fix and prevent waste in cloud infrastructure and AI workloads. Adaptive6 helps enterprise engineering and FinOps teams find, fix and prevent waste in cloud infrastructure and AI workloads. | $28M | Series A | Developer tools | United States | Investors | |
| CT CraniUS TherapeuticsCompany profile Develops implantable platform to bypass blood-brain barrier for drug delivery Develops implantable platform to bypass blood-brain barrier for drug delivery | $20M | Series B | Healthtech | United States | Investors Undisclosed | |
| O OriginCompany profile Provides pelvic floor physical therapy and whole-body musculoskeletal care for women Provides pelvic floor physical therapy and whole-body musculoskeletal care for women | Undisclosed | Series B | Healthtech | United States | Investors | |
| SB Stellular BioCompany profile Develops platelet-derived regenerative biologic therapeutics for ocular surface diseases Develops platelet-derived regenerative biologic therapeutics for ocular surface diseases | Undisclosed | Series A | Biotech | United States | Investors | |
| CT Curate TechnologiesCompany profile Provides white-labeled no-download mobile ordering and loyalty experiences for restaurants Provides white-labeled no-download mobile ordering and loyalty experiences for restaurants | $10M | Undisclosed | Foodtech | United States | Investors | |
| RM Redwood MaterialsCompany profile Recycles batteries and produces cathode materials for energy storage Recycles batteries and produces cathode materials for energy storage | $425M | Series ESeries C+ | Climate tech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
133rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
100rounds20led - 3General Catalyst
Hyperbolic, Re:Build, Provision Labs
73rounds8led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Sequoia Capital
Hex, Warhound, Whop
58rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.